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Abstract Somatic symptom disorder (SSD) is deﬁned by the prominence of somatic symptoms associated
with abnormal thoughts, feelings, and behaviors related to the symptoms, resulting in signiﬁcant distress
and impairment. Individuals with these disorders are more commonly encountered in primary care and other
medical settings, including dermatology practice, than in psychiatric and other mental health settings. What
deﬁnes the thoughts, feelings, and behaviors as abnormal is that they are excessive, that is, out of proportion
to other patients with similar somatic symptoms, and that they result in signiﬁcant distress and impairment.
SSD may occur with or without the presence of a diagnosable dermatologic disorder. When a dermatologic
disorder is present, SSD should be considered when the patient is worrying too much about his or her skin,
spending too much time and energy on it, and especially if the patient complains of many nondermatologic
symptoms in addition. The differential diagnosis includes other psychiatric disorders, including depression,
anxiety disorders, delusions of parasitosis, and body dysmorphic disorder.
This paper describes SSD and its applicability in dermatologic practice, with illustrative cases.
© 2017 Elsevier Inc. All rights reserved.

Somatic symptom disorder
The distinguishing characteristic of somatic symptom disorder (SSD) lies in the way the patient presents, interprets,
and responds to the symptoms rather than to the somatic symptoms themselves. As a result, the diagnostic criteria for SSD
include disproportionate emotional, cognitive, and behavioral
manifestations, key to deﬁning the disorders.1–4
The creation of SSD is due to the changes that occurred
from DSM-IV to DSM-5.1,2 In DSM-IV, psychiatric conditions primarily presenting in medical settings with physical
symptoms were grouped together as the “somatoform disorders,” which included somatization disorder, hypochondriasis,
pain disorders, and conversion disorder. The authors of DSM⁎ Corresponding author. Tel.: +1 804 828 0763.
E-mail address: james.levenson@vcuhealth.org (J.L. Levenson).
http://dx.doi.org/10.1016/j.clindermatol.2017.01.010
0738-081X/© 2017 Elsevier Inc. All rights reserved.

5 recognized the overlap between the somatoform disorders
and a lack of clarity about the boundaries of these DSM-IV diagnoses. DSM-5 sought to reduce the total number of disorders, as well as their subcategories, to make diagnosis more
straightforward for nonpsychiatric physicians encountering
patients with these symptoms. Patients who previously would
have been found to have somatization disorder and most of
those with hypochondriasis or pain disorders now have the
new diagnosis of SSD.
The change is not just semantic but conceptual. Previous
(DSM-III, DSM-IIIR, and DSM-IV) criteria emphasized the
centrality of medically unexplained symptoms in diagnosing
somatoform disorders. DSM-5 removed this requirement for
several reasons. The reliability of determining that a somatic
symptom is medically unexplained is limited, and grounding
a diagnosis in the absence of an explanation is problematic
and reinforces mind-body dualism. A mental disorder diagnosis should not be made solely, because a medical cause for
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Diagnostic criteria for somatic symptom disorder

A. One or more somatic symptoms that are distressing or result in signiﬁcant disruption of daily life
B. Excessive thoughts, feelings, or behaviors related to the somatic symptoms or associated health concerns as manifested by at least one of
the following:
a. Disproportionate and persistent thoughts about the seriousness of one’s symptoms
b. Persistently high level of anxiety about health or symptoms
c. Excessive time and energy devoted to these symptoms or health concerns
C. Although any one somatic symptom may not be continuously present, the state of being symptomatic is persistent (typically more than 6
months).
Specify if:
With predominant pain (previously pain disorder): This speciﬁer is for individuals whose somatic symptoms predominantly involve pain.
Specify if:
Persistent: A persistent course is characterized by severe symptoms, marked impairment, and long duration (more than 6 months).
Specify current severity:
Mild: Only one of the symptoms speciﬁed in criterion B is fulﬁlled.
Moderate: Two or more of the symptoms speciﬁed in criterion B are fulﬁlled.
Severe: Two or more of the symptoms speciﬁed in criterion B are fulﬁlled, plus there are multiple somatic complaints (or one very severe
somatic symptom).
Reproduced with permission from the Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (Copyright © 2013), American Psychiatric Association.
All Rights Reserved.

physical signs and symptoms cannot be shown. In addition,
the presence of a medical diagnosis does not exclude the possibility of a comorbid mental disorder. A psychiatric diagnosis
should be based primarily on the presence of abnormal psychologic symptoms and signs.
The new (DSM-5)1 classiﬁcation deﬁnes the major diagnosis of SSD on the basis of positive symptoms, namely, distressing somatic symptoms plus abnormal thoughts, feelings, and
behaviors in response to these symptoms, rather than an absence of a medical explanation for the somatic symptoms.
What deﬁnes the thoughts, feelings, and behaviors as abnormal is that they are excessive, that is, out of proportion to other
patients with similar somatic symptoms, and that they result in
signiﬁcant distress and impairment.
Some mental disorders, including major depressive disorder or panic disorder, may initially manifest with primarily somatic symptoms. Such diagnoses may account for the somatic
symptoms, or they may be comorbid with one of the somatic
symptom and related disorders. The somatic component adds
severity and complexity to depressive and anxiety disorders
and results in higher severity, functional impairment, and even
refractoriness to traditional treatments. The criteria for SSD are
shown in Table 1. The prevalence of SSD is unknown, but in
the general adult population it may be around 5-7%. Women
tend to report more somatic symptoms.
Several factors contribute to somatic symptom and related
disorders, including genetic and biologic vulnerability, early
traumatic experiences, and learning, as well as cultural/social
norms that devalue and stigmatize psychologic suffering compared with physical suffering. Variations in symptom presentation are often due to the interaction of many factors within

cultural contexts that inﬂuence how a person may identify or
classify sensation, interpret illness, and seek medical help.
SSD occurs across the age spectrum.5
The core features of SSD are multiple somatic symptoms (or
one severe symptom) that are distressing and result in signiﬁcant impairment: Worrying too much about the somatic symptoms, plus spending too much time and energy on them. In
dermatology practice, the somatic symptoms may be entirely focused on the skin, with pruritus or pain being most common, or
the cutaneous symptoms may accompany other symptoms,
such as headache, back pain, fatigue, gastrointestinal symptoms,
chest pain, shortness of breath, and paresthesias.
In addition to multiple symptoms, SSD patients often present vague and inconsistent histories expressing dissatisfaction
with previous care received. They are often viewed as “difﬁcult patients.” The symptoms and related concerns often dominate the patient’s life, and psychosocial functioning declines.
Many patients engage in excessive self-monitoring to reassure
themselves, for example, checking their skin frequently or repeatedly measuring blood pressure and pulse. Patients with
SSD often seek remedies through complementary/alternative
practitioners, and consume vitamins, over-the-counter remedies, and fad diets. Many patients devote excessive amounts
of time on the Internet reading about medical diseases and
treatments.
SSD can occur with or without a general medical illness
that can “explain” their somatic symptoms. When such an illness is present (eg, psoriasis), SSD can be diagnosed when the
patient’s cognitive-emotional-behavioral response to the skin
disease is clearly excessive compared with most other patients
with that same skin disorder of similar severity. Patients with
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SSD often have signiﬁcant depression and/or anxiety and may
qualify for an additional psychiatric diagnosis. Patients with
more severe SSD also frequently have personality disorders,
in addition to depression and anxiety, making their management more difﬁcult. Patients with SSD vary in their degree
of insight. Some recognize that they have overreacted to their
physical symptoms, whereas others do not see that their reactions are excessive; however, their beliefs about their symptoms are not delusional; that is, their somatic symptoms and
worries are plausible and not bizarre.
The excessive focus on their symptoms and the high level
of health anxiety often result in high health care utilization.
Multiple physical examinations and tests that are explained
as normal typically do not allay the patient’s concern.
Doctor-shopping, duplicated progressively more invasive diagnostic tests (eg, biopsy of skin, lymph node, and nerve),
and higher-risk treatments may result, which can reinforce
the sick role and increase the risk of iatrogenic complications.
Despite extensive medical attention, patients with SSD often
are disappointed and frustrated with the care they have received. Physicians become frustrated, because their efforts to
help and reassure the patient are ineffective.
The diagnosis of SSD requires taking a full history, including a review of systems (not just the presenting dermatologic
symptom), performing a physical examination, and reviewing
prior medical care. Many will have seen several prior physicians and have been dissatisﬁed. The history may reveal a pattern of multiple physical symptoms, excessive health care
utilization, doctor-shopping, and greater psychosocial impairment than expected. Even when the physical complaint seems
grossly exaggerated, a medical etiology should be considered
so that patients feel that they are being taken seriously, and because SSD can be a maladaptive response to a signiﬁcant medical illness. Establishing trust and avoiding the patients feeling
disrespected or humiliated are essential. Telling patients that
there is nothing wrong with them or that they are making too
big a deal out of their symptoms is not helpful and risks further
antagonizing patients.
In taking a history of the present illness, the dermatologist
should note how the physical symptoms are related to the patient’s life circumstances and emotions, particularly if any
stressful events have occurred. What exacerbates or alleviates
the symptoms? What do patients think is wrong and how seriously ill do they think they are? How much time, energy, worry, and thought do they devote to the somatic symptoms? The
physical examination should help to satisfy the physician that
the patient does not have a medical disease, or if there is one,
provide a perspective on its severity. Patients are more likely
to believe that their complaints are taken seriously when a
physical examination is performed. Decisions about diagnostic
tests, especially invasive ones, should be based on objective
signs rather than on the volume of the symptom complaint
expressed by the patient. Physicians often bear responsibility
for pursuing excessive diagnostic testing, even when there
are clear indications that the etiology is psychiatric.6,7 Diagnostic tests are often ordered to provide reassurance, even
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when the physician has concluded that there is no signiﬁcant
risk of serious disease.8 Unfortunately, such testing does not
reassure patients.9
How should the diagnosis of SSD be discussed with patients? Regardless of suspected etiology, physicians should
convey to patients that they regard the symptoms as real (eg,
they are not “all in your head”). When no medical disorder
has been identiﬁed, physicians should avoid debating whether
the symptoms are due to a medical or psychiatric cause. Directly challenging patients’ beliefs about their symptoms
may undermine the doctor-patient relationship. When there is
an identiﬁed medical disorder about which patients are disproportionately concerned, it can be counterproductive to tell
them that their complaints have been blown out of proportion,
as this risks their feeling discounted and disrespected. Instead,
one should start with empathic reﬂection that recognizes the
burden the somatic symptoms have been on the patient. This
may be followed by an explanation of how sensitivity to pain,
itching, or other physical symptoms is affected by stress and
coping style.
The differential diagnosis of SSD includes both medical
and psychiatric disorders.1 If the somatic symptoms are consistent with another mental disorder and the diagnostic criteria
for that disorder are satisﬁed, the mental disorder should be
considered as an alternative diagnosis. Patients can have both
SSD and another psychiatric disorder simultaneously.
1. Panic disorder: In panic disorder, the somatic symptoms and anxiety regarding health occur in acute intermittent episodes, as opposed to SSD, where the
anxiety and somatic symptoms remain persistent.
2. Generalized anxiety disorder: In generalized anxiety
disorder there is worry about multiple events, situations,
or activities, which may involve their health. The focus
is less likely to remain on somatic symptoms or fear of
illness as it is in SSD.
3. Depressive disorders: Depressive disorders may present
with somatic symptoms; however, the distinction lies in
the presence of core depressive symptoms of dysphoria
and anhedonia.
4. Illness anxiety disorder: Illness anxiety disorder involves extensive worry about health without symptoms
or with minimal somatic symptoms.
5. Conversion disorder: Conversion disorder includes the
loss of function, whereas in SSD the emphasis remains
on the distress that the particular symptom is causing.
Criterion B helps to distinguish these two disorders.
6. Delusional disorder: In SSD, the individual’s beliefs
that the somatic symptoms might reﬂect serious underlying physical illness are not held with delusional intensity. In delusional disorder, somatic subtype, the
somatic symptom beliefs and behavior are stronger than
those found in SSD.
7. Body dysmorphic disorder: In body dysmorphic disorder, the individual is excessively preoccupied with a
perceived defect in physical features. In SSD, the

Somatic symptom disorder
concern is with underlying illness compared with physical appearance.
8. Obsessive-compulsive disorder: In SSD, there is less severity in the recurrence of ideas about the somatic symptoms and there are no associated repetitive behaviors to
reduce anxiety, as seen in obsessive-compulsive disorder.

Case examples
A patient with SSD and minor dermatologic disease
Case 1
A 51-year-old woman with diabetes mellitus, peripheral neuropathy, hyperlipidemia, hypertension, and low back pain presented for evaluation of “warts” on her hands and feet. The
“warts” began in 2008, which the patient attributed to working
as a nurse. She described the plantar warts as painful and worsened by walking or even standing. During the interview, the patient pointed to numerous places on her palms, ﬁngers, and
dorsal distal interphalangeal (DIP) joints. When she applied aloe
vera, they “popped out.” They could move from one place to another, and she heard them popping when she rubbed her skin.
She washed her hands several times daily after going to the
bathroom. The patient had seen numerous doctors who, she reported, thought she was “crazy” and prescribed her lorazepam.
In 2014, a dermatologist performed cryotherapy, providing
some relief. She expressed interest in repeat cryotherapy.

Physical examination
On initial examination, her hands showed a few small 1-mm
vesicles, despite the patient pointing to various locations of
“warts” that appeared to be clinically normal skin. Two vesicles
were noted on the left palmar thenar eminence, and one was noted on the left middle digit (palmar aspect). The palmar aspect of
both hands showed mild diffuse hyperkeratinization. In addition, bony overgrowth of DIP joints and diffuse verrucous
hyperkeratinization was appreciated. The patient had a hyperpigmented macule on her thumb, which the patient considered
a collection of warts. On her feet, diffuse hyperkeratosis of pressure areas on the plantar feet was present. She was alert and oriented and maintained a cooperative, appropriate mood and
affect.

Discussion
This represents SSD with a nonspeciﬁc dermatitis as the
cause of her symptoms. She misperceives a normal variation
in her skin as evidence of signiﬁcant pathology. She presents
with signiﬁcant pain and is very concerned about recurrent
“warts.” She does have dyshidrosis with some mild postinﬂammatory hyperpigmentation, but she does not have evidence of verrucae. She has consulted many physicians and
pushes for multiple interventions.
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The best approach would be to redirect the patient by thoroughly explaining the most likely diagnosis: Dyshidrosis.

Patients with signiﬁcant dermatologic disease whose
thoughts, emotions, and/or behavior are out of
proportion to their dermatologic disease
Case 2
A 45-year-old woman with anxiety presented to the dermatology clinic with a generalized eruption present for 4 months
and induced by insect bites. She had seen another physician 1
week after the onset, who conﬁrmed an insect bite reaction.
Topical steroids were moderately helpful; however, she continued to feel tingling with “pins and needles” sensations. In
addition, she noticed linear skin eruptions on her face and
scalp, making her extremely concerned that these might represent something more serious or even life threatening that now
interfered with her work. She feels that previous medical evaluation and treatment have not been adequate and is very worried that her symptoms represent something more serious than
bug bites.

Physical examination
On initial examination, there were scattered erythematous
papules with linear crusted papules, some conﬂuent on the
right leg. She had 5/5 strength in the upper and lower extremities. Light touch, pinprick, position sense, and vibration sense
were intact in ﬁngers and toes. She was alert and oriented and
seemed cooperative, with appropriate mood and affect.

Discussion
This patient anxiously presented to clinic for nonspeciﬁc
dermatitis concerned that something more serious was affecting her. If the objective ﬁndings on examination had been
more concerning, then it would have been appropriate to do
further medical evaluation; however, in this case there did
not appear to be an indication for further testing. The patient
showed thoughts, feelings, and behaviors that were out of proportion to other patients with similar somatic symptoms of a
diagnosable dermatologic disease, in this case insect bites,
and it resulted in signiﬁcant distress and impairment, consistent with SSD.
Case 3
A 48-year-old woman with ﬁbromyalgia and questionable
attention-deﬁcit/hyperactivity disorder presented with a 3-year
history of upper torso ﬂushing with diaphoresis of the upper half
of her body, and pruritus with crawling sensations on her forehead. She previously underwent an extensive evaluation by endocrinology for carcinoid syndrome, pheochromocytoma, and
hyperthyroidism but ultimately attributed her symptoms to
methylphenidate taken for attention-deﬁcit/hyperactivity disorder. The symptoms persisted after discontinuation of the drug.
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Concurrently, a previous dermatologist had found her to have
rosacea. She was looking for a second opinion because she
was dissatisﬁed with both diagnoses. From her reading on the
Internet she was very concerned about having cancer, and she
complained that the previous physicians had not listened to
her. She insisted on further laboratory tests and imaging.

Physical examination
On physical examination, there were mild erythematous
patches on the forehead, cheeks, and chin. No other skin
changes were noted. She was alert and oriented, anxious, and
exhibited appropriate mood.

Discussion
It is common in patients with SSD that physicians devote
excessive attention to ruling out rare disorders as explanation
for the patient’s difﬁcult-to-explain symptoms, in this case carcinoid syndrome and pheochromocytoma. This led to the patient continuing to worry that she had an occult disorder
even after extensive evaluation had found no evidence.
The distinguishing characteristic of SSD lies in the way the
patient presents, interprets, and responds to the symptoms rather than the somatic symptoms themselves. As such, patients
will exhibit disproportionate emotional, cognitive, and behavioral manifestations, key to deﬁning the disorder. This patient
shows disproportionate behavioral and cognitive manifestations such as seeking multiple opinions, requesting additional
imaging, and doing extensive research on her own to explain
her symptoms.
Patients’ symptoms should never be discounted solely due
to atypical presentation or previous psychiatric history. In this
case, the patient started out with a dermatologic symptom of
probable drug-induced ﬂushing; however, she continued to
complain of symptoms even after the medication was stopped.
She continued to worry despite the negative medical workup
and her physicians’ reassurance, thus pointing to SSD. The
role of the dermatologist was to explain rosacea, and that
ﬂushing can be benign.

Examples that are not SSD
Case 4
A 50-year-old man with a history of hemochromatosis presented with chronic cutaneous ulcers on his neck and face,
with a ﬂuctuating course alternating between healing and
breaking open. He had seen several providers for this and
has had a negative skin biopsy. He has taken several courses
of oral and IV antibiotics, and chronically used topical bacitracin. He is concerned that there are parasites in the wound, and
admits to frequently scratching and removing what he believes
are insect eggs. He has brought samples along with several pictures of the “bugs.” Despite multiple providers’ reassurance,
he continues to insist that he is infested.
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Physical examination
On physical examination, there was a very large ulcer
with surrounding erythema on his right neck, and a large irregularly shaped hypopigmented scar on his left neck. He
also had a superﬁcial ulcer on his left cheek, along with a
few shallow ulcers on his left leg. He was alert and oriented,
seemed cooperative, and exhibited appropriate mood and
affect.

Discussion
This is a case of a 50-year-old man with a classic history
and ﬁndings consistent with delusions of parasitosis as the
likely diagnosis. When a different psychiatric diagnosis accounts for a patient’s symptoms, it should be used rather than
SSD. In this case the patient has delusional beliefs about infestation and in DSM-5 would be diagnosed as having a delusional disorder, somatic type.
How to manage delusions of parasitosis is outside the scope
of this paper (see a recent review for practical suggestions10),
but in such patients it is always important to be on the lookout
for superimposed staphylococcal or other secondary infections, or underlying systemic illnesses (eg, hepatic or renal insufﬁciency, stimulant abuse) that can cause secondary
delusions of parasitosis.

Conclusions
When a patient is encountered in dermatology practice with
prominent cutaneous symptoms causing the patient signiﬁcant
distress and/or impairment, either in the absence of objective
signs of disease, or grossly disproportionate to a diagnosed
dermatologic condition, the diagnosis of SSD should be considered. The key features of SSD are the abnormal and excessive thoughts (eg, constant worry that one has cancer), feelings
(eg, overwhelming anxiety), and behaviors (eg, constant
checking of one’s skin) related to the symptoms. The presence
of many nondermatologic symptoms in addition to the
cutaneous ones is further suggestive of SSD. The differential
diagnosis includes other psychiatric disorders frequently seen
in dermatology, including depression, anxiety disorders,
obsessive-compulsive disorder, delusions of parasitosis, and
body dysmorphic disorder. After taking a history, careful
examination and empathic explanation to the patient can avoid
unnecessary, costly, and potentially harmful testing and
biopsies.
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